Refractory Pancreatic Carcinoma
6 clinical trials · Condition
◉ Watch Refractory Pancreatic Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumors and Lymphomas (NCT03925428) | National Cancer Institute (NCI) | 2020-09-18 |
| A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors (NCT03784677) | M.D. Anderson Cancer Center | 2019-07-29 |
| M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT02595931) | National Cancer Institute (NCI) | 2016-07-22 |
Track Refractory Pancreatic Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.